Cardiac Arrhythmia Classification Using Sample Entropy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cardiac rhythm management systems face challenges in accurately classifying tachyarrhythmias, such as distinguishing between tachycardia and fibrillation, which is crucial for selecting appropriate therapy to restore normal cardiac function.
Innovation Solution
An implantable medical device with an arrhythmia detection and classification system that uses irregularity and complexity parameters, computed using sample entropy, to classify arrhythmias based on cycle length irregularity and morphological complexity of cardiac signals, enabling discrimination between tachycardia and fibrillation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional arrhythmia classification methods are used, then the system can detect tachyarrhythmias, but the classification accuracy between tachycardia and fibrillation is insufficient
Solution Approach 1:
The classification system is divided into multiple independent analysis modules: cycle length irregularity analysis, morphological complexity analysis, and therapy selection. Each module processes specific features independently, improving classification accuracy without requiring a complete system redesign.
Solution Approach 2:
The patent introduces sample entropy as a new dimensional parameter for analyzing cardiac signals. By computing sample entropy of cycle lengths and morphological features, the system adds a quantitative dimension to arrhythmia classification, enabling better discrimination between tachycardia and fibrillation beyond traditional rate-based methods.
2Reliability
If defibrillation shock pulses are delivered for all tachyarrhythmias, then life-threatening conditions are treated, but unnecessary shocks are delivered for non-life-threatening arrhythmias causing substantial discomfort
Solution Approach 1:
The therapy selection is made dynamic based on real-time classification results. The system continuously monitors arrhythmia characteristics and adjusts therapy delivery accordingly: ATP is delivered for tachycardia while defibrillation is reserved for fibrillation, making the treatment adaptive rather than static.
Solution Approach 2:
The classification system provides feedback to the therapy delivery mechanism. By analyzing cycle length irregularity and morphological complexity, the system determines whether the detected arrhythmia requires defibrillation or can be treated with less invasive ATP, creating a feedback loop that prevents unnecessary shock delivery.
3Reliability
If ATP therapy is delivered for all detected tachyarrhythmias, then non-life-threatening arrhythmias are treated appropriately, but life-threatening fibrillation may not receive immediate defibrillation
Solution Approach 1:
The system performs preliminary classification of the arrhythmia type before determining therapy. By analyzing cycle length irregularity and morphological complexity in advance, the system pre-determines whether ATP or defibrillation is appropriate, ensuring that life-threatening fibrillation receives immediate defibrillation without delay while ATP is reserved for suitable tachycardia cases.
Data Source
AI summary
An implantable medical device includes an arrhythmia detection and classification system that classifies an arrhythmia episode based on an irregularity parameter and/or a complexity parameter. The arrhythmia episode is detected from a cardiac signal. The irregularity parameter is indicative of the degree of cycle length irregularity of the cardiac signal and the complexity parameter is indicative of the degree of morphological complexity of the cardiac signal. One example of the irregularity parameter is an irregularity sample entropy, or a parameter related to the irregularity sample entropy, computed to indicate the cycle length irregularity. One example of the complexity parameter is a complexity sample entropy, or a parameter related to the complexity sample entropy, computed to indicate the morphological complexity. In one embodiment, the detected arrhythmia episode is classified using both the irregularity parameter and the complexity parameter.